Consider automation early in the rollout of clinical translation and scale up of clinical-trial protocols.
James B Morrissey
Advertisement
James B Morrissey is bioengineering scientist-Cocoon Program, Octane Biotech Inc.
Articles by James B Morrissey
Advertisement
Latest Updated Articles
End-to-End Cell Therapy Automation: An Immunotherapy Case StudySeptember 15th 2017
Advertisement
Advertisement